1 Product identity
Ingredient risk
1 ingredient to use with caution
Magnesium Oxide Tablets 400 mg
BrandQualitest→Mineral Tablet or Pill 5 ingredients 1 caution DSLD #240151Net contents: 120 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2020-11-21
2 Ingredients (5)
IngredientGroupSafety
Microcrystalline CelluloseCellulose—
Stearic AcidStearic Acid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID240151
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2020-11-21
6 More from Qualitest
View Qualitest Safety Scorecard → 6 products
Ferrous Sulfate Tablets 325 mgFerrous Sulfate Tablets 325 mgMulti-Vit With Fluoride 0.25 mg And Iron DropsMulti-Vit With Fluoride 0.5 mg DropsTri-Vit With Fluoride 0.25 mg Drops7 Cite this page
Vancouver
Pkhakadze G. Magnesium Oxide Tablets 400 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/magnesium-oxide-tablets-400-mg-240151/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG